We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Papaya Leaf Extract Slows Growth of Cancer Cell Cultures

By LabMedica International staff writers
Posted on 23 Mar 2010
Cancer researchers have found that a water extract prepared from dried papaya leaves has potent anticancer properties when tested on cultures of cells taken from more than 10 different types of tumors.

Investigators at the University of Florida (Gainesville, FL, USA) and the University of Tokyo (Japan) sought to bring scientific order to folk anecdotes on the anticancer properties of papayas. More...
Their plan was to examine the effect of an aqueous-extracted papaya leaf fraction on the growth of various tumor cell lines and on the antitumor effect of human lymphocytes. In addition, they attempted to identify the functional molecular weight fraction in the papaya leaf extract. In this study the effect of papaya leaf extract on the proliferative responses of tumor cell lines and human peripheral blood mononuclear cells (PBMC), and cytotoxic activities of PBMC were assessed by the incorporation of radioactive thymidine. Flow cytometric analysis and measurement of caspase-3/7 activities were performed to confirm the induction of apoptosis on tumor cells. Cytokine productions by PBMC were measured by ELISA. Gene profiling of the effect of leaf extract treatment was performed by microarray analysis and real-time RT-PCR.

Results published in the February 17, 2010, issue of the Journal of Ethnopharmacology revealed that papaya leaf extract showed significant growth inhibitory activity on cervix, breast, liver, lung, and pancreas tumor-cell lines. In PBMCs, the production of interleukin-2 (IL-2) and IL-4 was reduced following the addition of leaf extract, whereas that of IL-12p40, IL-12p70, IFN-gamma (interferon-gamma) and TNF-alpha (tumor necrotic factor-alpha) was enhanced without growth inhibition. In addition, cytotoxicity of activated PBMCs was enhanced by the addition of the extract. Moreover, microarray analyses showed that the expression of 23 immunomodulatory genes, classified by gene ontology analysis, was enhanced by the addition of papaya leaf extract.

The investigators identified the active component of the papaya leaf extract, which inhibited tumor cell growth and stimulated anti-tumor effects, to be a fraction with molecular weight less than 1,000. Importantly, the papaya extract did not have any toxic effects on normal cells.

"Based on what I have seen and heard in a clinical setting, nobody who takes this extract experiences demonstrable toxicity; it seems like you could take it for a long time — as long as it is effective,” said contributing author Dr. Nam Dang, professor of hematology and oncology at the University of Florida.

Related Links:
University of Florida
University of Tokyo



Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Varicella Zoster Virus Assay
LIAISON VZV Assay Panel (IgG HT, IgM)
New
Myocardial Infarction Test
Finecare cTn I/NT-proBNP Rapid Quantitative Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Gut microbes may help in recognizing and treating pancreatic cancer (Photo courtesy of Adobe Stock)

Gut Microbes Could Enable Early Detection and Treatment of Pancreatic Cancer

Pancreatic cancer remains one of the most serious and challenging diseases in oncology due to its difficulty in detection and limited treatment options. Now, a new international collaborative study suggests... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Microbiology

view channel
Image: The U.S. FDA-cleared IntelliSep rapid host response diagnostic represents a breakthrough in sepsis care (Photo courtesy of Cytovale)

Rapid Diagnostic Test Slashes Sepsis Mortality by 39%

Sepsis remains one of the most challenging and fatal conditions in contemporary healthcare, accounting for nearly one-third of all hospital-related deaths in the United States. In emergency departments... Read more

Industry

view channel
Image: The knowledge transfer partnership will further develop technology to rapidly diagnose serious and high-risk infectious diseases (Photo courtesy of Aston University)

Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic

Technology that can rapidly diagnose high-consequence infectious diseases will take a major step forward towards commercialization, thanks to a new partnership. A Knowledge Transfer Partnership (KTP)... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.